Tetracyclines and their Derivatives; Salts Thereof
Código 294130 (Harmonized System 2012 by 6 digits)
2023: US$14.8M, Total Trade Exchange
2023: US$200k, International Sales
2023: US$14.6M, International Purchases
Código 294130 (Harmonized System 2012 by 6 digits)
2023: US$14.8M, Total Trade Exchange
2023: US$200k, International Sales
2023: US$14.6M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Tetracyclines and their Derivatives; Salts Thereof was US$14.8M.
In 2018, the states with the most international sales in Tetracyclines and their Derivatives; Salts Thereof were Ciudad de México (US$42.8k).
The states with the most international purchases in 2023 were Ciudad de México (US$7.46M), Jalisco (US$3.37M), and Estado de México (US$3.29M).
In 2018, the main commercial destinations of Tetracyclines and their Derivatives; Salts Thereof were Brazil (US$42.8k), Ireland (US$43), United States (US$2), and France (US$1).
The main commercial origins of Tetracyclines and their Derivatives; Salts Thereof in 2023 were China (US$6.8M), Italy (US$5.36M), Ireland (US$1.43M), Portugal (US$440k), and Macau (US$53.7k).
In the global context, the main exporting countries of Tetracyclines and their Derivatives; Salts Thereof in 2022 were China (US$455M), Ireland (US$124M), and Belgium (US$82.1M). In the same year, the main importing countries of Tetracyclines and their Derivatives; Salts Thereof were Italy (US$138M), Belgium (US$97.1M), and Netherlands (US$54.1M).
US$14.8M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Tetracyclines and their Derivatives; Salts Thereof in Mexico (including international purchases and sales) was US$14.8M.
The visualizations show the net balance of Tetracyclines and their Derivatives; Salts Thereof at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$871k, International Purchases
In November 2024, international sales of Tetracyclines and their Derivatives; Salts Thereof were US$0, while international purchases reached US$871k. The above results in a trade balance of -US$871k.
Ciudad de México: US$42.8k, State with the Most International Sales (2018)
Brazil: US$42.8k, Main commercial destination (2018)
In 2018, the states with the highest international sales in Tetracyclines and their Derivatives; Salts Thereof were Ciudad de México (US$42.8k).
In 2018, the countries with the most international purchases from Mexico were Brazil (US$42.8k), Ireland (US$43), United States (US$2), and France (US$1).
Ciudad de México: US$7.46M, State with the Most International Purchases (2023)
China: US$6.8M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Tetracyclines and their Derivatives; Salts Thereof were Ciudad de México (US$7.46M), Jalisco (US$3.37M), and Estado de México (US$3.29M).
The countries with the most international sales to Mexico in 2023 were China (US$6.8M), Italy (US$5.36M), Ireland (US$1.43M), Portugal (US$440k), and Macau (US$53.7k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Tetracyclines and their Derivatives; Salts Thereof and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Tetracyclines and their Derivatives; Salts Thereof. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Tetracyclines and their Derivatives; Salts Thereof. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Tetracyclines and their Derivatives; Salts Thereof were China (US$455M), Ireland (US$124M), and Belgium (US$82.1M). In the same year, the main importing countries for Tetracyclines and their Derivatives; Salts Thereof were Italy (US$138M), Belgium (US$97.1M), and Netherlands (US$54.1M).